NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
531 Skövde

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 523 4.9% 73 0.7% 18 0.2% . . 5 0.0% 12 0.1% 9946 94.0% 10577 100.0%
ASCUS 455 32.5% 238 17.0% 154 11.0% 3 0.2% 3 0.2% 14 1.0% 534 38.1% 1401 100.0%
LSIL 122 28.0% 139 31.9% 92 21.1% 1 0.2% . . 1 0.2% 81 18.6% 436 100.0%
Atypical glandular cells/AGC 27 38.0% 12 16.9% 10 14.1% 6 8.5% 7 9.9% 2 2.8% 7 9.9% 71 100.0%
Unclear atypia 2 100.0% . . . . . . . . . . . . 2 100.0%
ASC-H 17 12.4% 16 11.7% 88 64.2% 4 2.9% 7 5.1% . . 5 3.6% 137 100.0%
HSIL 2 2.5% 3 3.7% 64 79.0% 1 1.2% 9 11.1% 1 1.2% 1 1.2% 81 100.0%
Suspected Adenocarcinom . . . . . . 1 11.1% 5 55.6% . . 3 33.3% 9 100.0%
Squamous cell cancer . . . . . . . . 1 100.0% . . . . 1 100.0%
Totalt 1148 9.0% 481 3.8% 426 3.4% 16 0.1% 37 0.3% 30 0.2% 10577 83.2% 12715 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M69760, M80009, M80703, M81403, M82603, M83803, M83806, M84413, M89803